cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2 has been researched along with alanine in 1 studies
Studies (cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2) | Trials (cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2) | Recent Studies (post-2010) (cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2) | Studies (alanine) | Trials (alanine) | Recent Studies (post-2010) (alanine) |
---|---|---|---|---|---|
5 | 0 | 0 | 24,468 | 512 | 5,581 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, S; Dratz, EA; Starkey, JR | 1 |
1 other study(ies) available for cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2 and alanine
Article | Year |
---|---|
Sidechain and backbone requirements for anti-invasive activity of laminin peptide 11.
Topics: Alanine; Animals; Basement Membrane; Drug Design; Female; Laminin; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasm Invasiveness; Oligopeptides; Thermodynamics; Tumor Cells, Cultured | 1998 |